Evolution of the Average Target: Genpact Limited

Evolution of the Average Target - Genpact Limited

Evolution of the Target Price: Genpact Limited

Evolution of the Target Price - Genpact Limited

Changes in Analyst Recommendations: Genpact Limited

944.As2dcZiqLfRcKSF1VIuGSG-l3ns30IXGGpMAUFi2mOE.SZyrP9CZRqMxfFYjNefQHyvunBVAn86nVcFWMxzG76hRgcoV0O5slx5IcA~11ca6c012182ec0c2b8295bcd3f0fe2e
08-07 Analyst recommendations: Micron Technology, Lockheed Martin, Airbnb, Johnson Controls International, The Allstate Corporation… Zonebourse
05-11 Mizuho Securities Adjusts Genpact Price Target to $39 From $49, Maintains Neutral Rating MT
12-12 Susquehanna Initiates Genpact With Neutral Rating, $50 Price Target MT
07/08/25 Genpact Q2 revenue, adjusted profit beats estimates RE
27/06/25 TD Cowen Raises Price Target on Genpact to $55 From $53, Maintains Buy Rating MT
10/02/25 Analyst recommendations: Drax, AstraZeneca, HSBC, Broadcom, Tesla... Zonebourse
10/02/25 Analyst recommendations: Aspen, Amazon, Mattel, Broadcom, Tesla… Zonebourse
07/02/25 Deutsche Bank Adjusts Genpact Price Target to $55 From $48, Maintains Hold Rating MT
07/02/25 TD Cowen Upgrades Genpact to Buy From Hold, Adjusts Price Target to $60 From $45 MT
21/01/25 Jefferies Upgrades Genpact to Buy From Hold, Adjusts Price Target to $55 From $44 MT
21/01/25 Analyst recommendations: Apple, On Holding, Amazon, Palo Alto Networks, Tesla... Zonebourse
11/11/24 Deutsche Bank Adjusts Genpact Price Target to $48 From $37, Maintains Hold Rating MT
11/11/24 Analyst recommendations: Moderna, Bristol-Myers Squibb Company, Regeneron Pharmaceuticals, Arista Networks... Zonebourse
17/07/24 JPMorgan Upgrades Genpact to Neutral From Underweight, Price Target is $40 MT
17/07/24 Analyst recommendations: American Airlines, Chevron, UnitedHealth, Bank of America, Eli Lilly... Zonebourse
30/01/24 Mizuho Securities Initiates Genpact With Neutral Rating, Price Target is $40 MT
17/01/24 Citigroup Adjusts Price Target on Genpact to $36 From $35, Maintains Neutral Rating MT
15/12/23 Baird Downgrades Genpact to Neutral From Outperform, Price Target is $38 MT
13/11/23 Wedbush Lowers Genpact's PT to $35 From $45 After Weaker-Than-Expected Q3 Results, Resets Full-Year 2023 Guidance; Keeps Neutral Rating MT
22/08/23 JPMorgan Downgrades Genpact to Underweight From Neutral, Price Target is $40 MT
11/08/23 Needham Adjusts Genpact Price Target to $50 From $56, Maintains Buy Rating MT
10/08/23 Deutsche Bank Adjusts Genpact Price Target to $37 From $48, Maintains Hold Rating MT
10/08/23 BMO Capital Adjusts Price Target on Genpact to $41 From $46, Maintains Market Perform Rating MT
18/07/23 Citigroup Downgrades Genpact to Neutral From Buy, Adjusts Price Target to $42 From $46 MT
11/05/23 JPMorgan Cuts Genpact's Price Target to $46 From $53, Neutral Rating Kept MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+5.09%
+4.28%
-2.58%
+17.6%
-0.23%
+28.37%
+77.02%
+12.8%
+12.7%
+15.58%
Average +17.06%
Weighted average by Cap. +8.82%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
40.83USD
Average target price
42.91USD
Spread / Average Target
+5.09%
High Price Target
58.00USD
Spread / Highest target
+42.05%
Low Price Target
36.00USD
Spread / Lowest Target
-11.83%

Analyst Consensus Detail

Analyst consensus - Genpact Limited

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Genpact Limited
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Genpact Limited
  1. Stock Market
  2. Stocks
  3. G Stock
  4. Consensus Genpact Limited